MAVIS edition 92

Marketing Authorisations Veterinary Information Service (MAVIS) edition 92


MAVIS edition 92

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


  • The Open Meetings of the VMD and VPC
  • Departure of Director of Authorisations
  • Electronic Invoices
  • The Second Round of VPP Inspections will start on 1 October 2014
  • ISO 9001 and ISO 27001: Successful Annual Surveillance Visits
  • Proposals from the EU Commission for Revised Law on Veterinary Medicines and Medicated Feedingstuffs
  • Horse Medicines: Revised Information for Owners and Keepers
  • Important Information for Cat and Dog Owners – Permethrin: Don’t Put Your Cat at Risk
  • Joint-Labelling between the UK and Ireland: Guidance for the Pharmaceutical Industry
  • Change of Legal Category for National or Mutually Recognised Products: Guidance for the Pharmaceutical Industry
  • Validation of New Marketing Authorisation Applications During the Christmas Period
  • Distribution of Veterinary Medicinal Products (VMPS): Guidance for the Pharmaceutical Industry
  • New Qualified Person (QP) Declaration Template
  • Pre-Assessment of Responses when Acting as RMS
  • Autogenous Vaccines – Changes to Application Process
  • Sheep Fly Strike Treatment Products
  • The VMD Phases Out the Importation of Virginiamycin for Veterinary Use
  • Top 10 Imported Veterinary Medicines Quarterly Report from 1 July to 30 September 2014
  • Seizure Notices
  • Improvement Notices
  • Outcomes of Prosecutions
  • Sales of NFA-VPS Online – Use of Disclaimers
  • Pharmacovigilance Quarterly Report
  • DARC Group Update
  • HMA-Veterinary Action Plan on Antimicrobial Issues
  • Sales Data Report and Antibiotic Resistance Surveillance Report
  • European Antibiotic Awareness Day (EAAD)
  • UK AMR Strategy
  • Meetings of the VPC
  • Meetings of the VRC
  • Residues Controls and Monitoring (Statutory and Non-Statutory)
  • Staff Changes
  • Marketing Authorisations
  • Annex 1 - Quarterly Reporting Against VMD Published Standards for Licensing Work 2014/15

MAVIS is designed to provide you with the best available information on the work of the Veterinary Medicines Directorate (VMD), our plans and results, as well as general developments on the controls of animal medicines. MAVIS is published quarterly and copies can be accessed from

Published 14 November 2014